Q2 2026 revenue rose 1% YoY to $15.0B, with adjusted EPS at $0.77, reflecting higher R&D spend but strong growth from new and acquired products. 2026 revenue guidance midpoint was raised to $61.5B, with robust pipeline progress and $9.7B in targeted cost savings through 2029.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.